# А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

> **NCT04524975** · PHASE2 · COMPLETED · sponsor: **ChemRar Research and Development Institute, LLC** · enrollment: 129 (actual)

## Conditions studied

- Anxiety Disorder Generalized

## Interventions

- **DRUG:** CD-008-0045
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04524975
- **Lead sponsor:** ChemRar Research and Development Institute, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-02
- **Primary completion:** 2019-08-20
- **Final completion:** 2019-11-01
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524975, "А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04524975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*